Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 4 2

Status

Terminated 1Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 1CNS 1Breast 1

Conditions

Prostatic Neoplasms 1Marijuana Abuse 1Glioblastoma 1Carcinoma, Intraductal, Noninfiltrating 1Cancer Pain 1Breast Carcinoma In Situ 1

Interventions

Specimen Handling 273Magnetic Resonance Spectroscopy 224pembrolizumab 214Carboplatin 173Biopsy 166Cisplatin 159Nivolumab 149Cyclophosphamide 133Radiotherapy 117Paclitaxel 117Gemcitabine 112Bevacizumab 92durvalumab 86Dexamethasone 80Rituximab 76Oxaliplatin 73atezolizumab 68Capecitabine 67venetoclax 66Fluorouracil 66Doxorubicin 65Docetaxel 65Etoposide 63Radiosurgery 60Radiation 57Prednisone 57Cytarabine 56Ipilimumab 55Pemetrexed 54Taxes 52

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Cannabidiol × 90 days × Clear all
NCT06538389 2026-04-30

High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer

City of Hope Medical Center

Phase 2 Recruiting
36 enrolled
Breast

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating

NCT07549256 2026-04-24

ProCan

Regionshospital Nordjylland

Phase 2 Not yet recruiting
58 enrolled
Genitourinary

Marijuana Abuse, Prostatic Neoplasms

NCT06533657 2026-04-21

UTOPIA-1

ZYUS Life Sciences Inc.

Phase 2 Completed
11 enrolled

Cancer Pain

NCT05753007 2026-03-16

A Clinical Trial of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma Patients

Mclean Hospital

Phase 2 Terminated
2 enrolled 13 charts
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡